title: Gain-of-function of Stat5 leads to excessive granulopoiesis and lethal extravasation of granulocytes to the lung.
abstract: The Signal Transducer and Activator of Transcription 5 (Stat5) plays a significant role in normal hematopoiesis and a variety of hematopoietic malignancies. Deficiency in Stat5 causes impaired cytokine-mediated proliferation and survival of progenitors and their differentiated descendants along major hematopoietic lineages such as erythroid, lymphoid, and myeloid cells. Overexpression and persistent activation of Stat5 are sufficient for neoplastic transformation and development of multi-lineage leukemia in a transplant model. Little is known, however, whether a continuous activation of this signal transducer is essential for the maintenance of hematopoietic malignancies. To address this issue, we developed transgenic mice that express a hyperactive mutant of Stat5 in hematopoietic progenitors and derived lineages in a ligand-controlled manner. In contrast to the transplant model, expression of mutant Stat5 did not adversely affect normal hematopoiesis in the presence of endogenous wildtype Stat5 alleles. However, the gain-of-function of this signal transducer in mice that carry Stat5a/b hypomorphic alleles resulted in abnormally high numbers of circulating granulocytes that caused severe airway obstruction. Downregulation of hyperactive Stat5 in diseased animals restored normal granulopoiesis, which also resulted in a swift clearance of granulocytes from the lung. Moreover, we demonstrate that Stat5 promotes the initiation and maintenance of severe granulophilia in a cell autonomous manner. The results of this study show that the gain-of-function of Stat5 causes excessive granulopoiesis and prolonged survival of granulocytes in circulation. Collectively, our findings underline the critical importance of Stat5 in maintaining a normal balance between myeloid and lymphoid cells during hematopoiesis, and we provide direct evidence for a function of Stat5 in granulophilia-associated pulmonary dysfunction.
authors.affiliation: Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
authors.forename: Wan-chi
authors.initials: WC
authors.lastname: Lin
authors.forename: Jeffrey W
authors.initials: JW
authors.lastname: Schmidt
authors.forename: Bradley A
authors.initials: BA
authors.lastname: Creamer
authors.forename: Aleata A
authors.initials: AA
authors.lastname: Triplett
authors.forename: Kay-uwe
authors.initials: KU
authors.lastname: Wagner
mesh_terms: D000483:Alleles; D000818:Animals; D006098:Granulocytes / Q000166:cytology* / Q000378:metabolism*; D006410:Hematopoiesis / Q000235:genetics / Q000502:physiology*; D008168:Lung / Q000166:cytology*; D051379:Mice; D008822:Mice, Transgenic; D050799:STAT5 Transcription Factor / Q000235:genetics / Q000378:metabolism*
chemical_list: D050799:STAT5 Transcription Factor
references.citation: Nature. 2005 Apr 28;434(7037):1144-8
references.pmid: 15793561
references.citation: PLoS Biol. 2008 Jun 24;6(6):e152
references.pmid: 18578569
references.citation: Blood. 2008 Apr 15;111(8):3931-40
references.pmid: 18160670
references.citation: Genes Dev. 2000 Jan 15;14(2):232-44
references.pmid: 10652277
references.citation: Immunity. 1999 Feb;10(2):249-59
references.pmid: 10072077
references.citation: Mol Cancer Res. 2002 Nov;1(1):32-47
references.pmid: 12496367
references.citation: Blood. 2006 Jun 15;107(12):4898-906
references.pmid: 16493008
references.citation: Clin Cancer Res. 2002 Apr;8(4):945-54
references.pmid: 11948098
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1000-5
references.pmid: 16418296
references.citation: Blood. 2003 Apr 15;101(8):3164-73
references.pmid: 12468433
references.citation: Mol Cell. 1999 Aug;4(2):199-207
references.pmid: 10488335
references.citation: Int J Cancer. 2004 Nov 20;112(4):607-19
references.pmid: 15382041
references.citation: Cell. 1998 May 29;93(5):841-50
references.pmid: 9630227
references.citation: N Engl J Med. 2005 Apr 28;352(17):1779-90
references.pmid: 15858187
references.citation: Mol Cell Biol. 2004 Sep;24(18):8037-47
references.pmid: 15340066
references.citation: J Cell Biochem. 1995 Dec;59(4):463-72
references.pmid: 8749716
references.citation: PLoS One. 2008;3(11):e3776
references.pmid: 19020663
references.citation: Immunol Rev. 2009 Mar;228(1):273-87
references.pmid: 19290934
references.citation: Lancet. 2005 Mar 19-25;365(9464):1054-61
references.pmid: 15781101
references.citation: Blood. 2005 Jan 1;105(1):324-34
references.pmid: 15331442
references.citation: Thorax. 2001 Sep;56(9):696-702
references.pmid: 11514690
references.citation: Blood. 2010 Sep 2;116(9):1528-38
references.pmid: 20489053
references.citation: J Biol Chem. 1999 Jun 11;274(24):16965-72
references.pmid: 10358045
references.citation: Blood. 2009 Nov 19;114(21):4721-8
references.pmid: 19779039
references.citation: Genes Dev. 1997 Jan 15;11(2):179-86
references.pmid: 9009201
references.citation: Mol Endocrinol. 2007 Aug;21(8):1877-92
references.pmid: 17519353
references.citation: PLoS One. 2007 Aug 15;2(8):e727
references.pmid: 17710127
references.citation: Blood. 2006 Apr 15;107(8):3303-12
references.pmid: 16380455
references.citation: Cell. 1999 Jul 23;98(2):181-91
references.pmid: 10428030
references.citation: Blood. 2007 Jul 1;110(1):116-24
references.pmid: 17374739
references.citation: Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7239-44
references.pmid: 9207075
references.citation: J Pediatr. 2011 May;158(5):701-8
references.pmid: 21414633
references.citation: Transgenic Res. 2010 Jun;19(3):499-509
references.pmid: 19821046
references.citation: Cancer Cell. 2005 Apr;7(4):387-97
references.pmid: 15837627
references.citation: Science. 2004 Jan 16;303(5656):359-63
references.pmid: 14671312
references.citation: Blood. 1997 Sep 1;90(5):1768-76
references.pmid: 9292509
references.citation: Nature. 2000 Mar 9;404(6774):193-7
references.pmid: 10724173
references.citation: Biochem Pharmacol. 2006 Mar 14;71(6):713-21
references.pmid: 16426581
references.citation: Genesis. 2009 Apr;47(4):234-45
references.pmid: 19208431
references.citation: Cancer Cell. 2004 Sep;6(3):241-9
references.pmid: 15380515
references.citation: N Engl J Med. 2003 Sep 18;349(12):1139-47
references.pmid: 13679528
references.citation: Exp Hematol. 2007 Nov;35(11):1684-94
references.pmid: 17976521
references.citation: Blood. 2009 May 14;113(20):4856-65
references.pmid: 19258595
references.citation: Pediatrics. 2006 Nov;118(5):e1584-92
references.pmid: 17030597
references.citation: EMBO J. 1999 Mar 1;18(5):1367-77
references.pmid: 10064602
references.citation: Oncogene. 2006 Aug 3;25(33):4573-84
references.pmid: 16532027
references.citation: PLoS One. 2012;7(8):e43778
references.pmid: 22952764
references.citation: J Clin Endocrinol Metab. 2005 Jul;90(7):4260-6
references.pmid: 15827093
references.citation: J Mammary Gland Biol Neoplasia. 2008 Mar;13(1):93-103
references.pmid: 18228120
references.citation: J Biol Chem. 2010 Oct 22;285(43):32704-32709
references.pmid: 20720003
references.citation: J Immunol. 2007 Jul 15;179(2):1068-79
references.pmid: 17617599
references.citation: Nat Genet. 2000 Jan;24(1):57-60
references.pmid: 10615128
references.citation: Blood. 2004 Feb 1;103(3):1085-8
references.pmid: 14504097
references.citation: Cancer Cell. 2005 Jan;7(1):87-99
references.pmid: 15652752